ACTRN12617001496303
Withdrawn
Not Applicable
Determining levels of Circulating Tumour Cells (CTCs) in blood for early detection and real-time treatment monitoring in cancer patients.
Survon Pte Ltd0 sites300 target enrollmentOctober 24, 2017
ConditionsCancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Survon Pte Ltd
- Enrollment
- 300
- Status
- Withdrawn
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Determining Circulating Tumour Cells (CTC) and other rare cells in cancer patients and for early detection screeningACTRN12614001143617Dr Karin Ried2,000
Completed
Not Applicable
Detection of circulating tumor cells (CTC) with novel viral marker (OBP-401) for patients with prostate cancerProstate cancerJPRN-UMIN000010410Department of Urology, Kobe university graduate school of medicine50
Completed
Phase 2
A quantification of circulating tumor cells in patients with gastric cancer by telomerase-specific oncolytic adenoviral agentsJPRN-UMIN000004026Digestive Disease Center, Showa University Nothern Yokohama Hospital200
Active, not recruiting
Not Applicable
Can cancer cells be found and counted in blood samples from patients with bone sarcoma?Specialty: Cancer, Primary sub-specialty: SarcomaUKCRC code/ Disease: Cancer/ Malignant neoplasms of bone and articular cartilageCancerSarcomaISRCTN29619083The Newcastle Upon Tyne Hospitals NHS Foundation Trust30
Completed
Not Applicable
Observational study in hepatocellular carcinoma (Liver Disease)Health Condition 1: null- HepatoCellular CarcinomaHealth Condition 2: K746- Other and unspecified cirrhosis ofliverCTRI/2018/02/011987Institute of liver and Biliary Sciences53